3rd Quarter - Termination — PODESTA GROUP, INC. for LIVESTRONG (2013)

Firm

PODESTA GROUP, INC.

Client

LIVESTRONG

Income

$30,000

Expenses

—

Terminated

Aug 31, 2013

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Healthcare systems and non-communicable disease funding.

Lobbyist	Covered position, as disclosed
DAVID ADAMS New	Leg. Director, Rep. Gary Ackerman
ARANTHAN JONES	—
MARK TAVLARIDES New	Sr. Spec. Asst., Office of Sec'y of Defense

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Healthcare systems and non-communicable disease funding. Impact of sequestration on cancer research and patient care.

Lobbyist	Covered position, as disclosed
ARANTHAN JONES	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Medicare/Medicaid MMM

Impact of sequestration on cancer research and patient care.

Lobbyist	Covered position, as disclosed
ARANTHAN JONES	—

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Health Issues HCR

Healthcare systems and non-communicable disease funding. Impact of sequestration on cancer research and patient care.

Lobbyist	Covered position, as disclosed
DAVID ADAMS New	Leg. Director, Rep. Gary Ackerman
ARANTHAN JONES	—
MARK TAVLARIDES New	Sr. Spec. Asst., Office of Sec'y of Defense

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.